OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

1 Projects | 1 Researchers | $98,484 Invested

2007

University of Pennsylvania

Christos Davatzikos, PhD

Predicting conversion from MCI to AD via 4-dimensional pattern analysis and classification of ADNI imaging data

  • Funding Amount: $98,484
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed